28th Mar 2022 10:11
Cambridge Cognition Holdings PLC- Cambridge, neuroscience technology company - Wins contract with an unnamed "top 10" pharmaceutical company. The contract worth over GBP1 million will see Cambridge Cognition provide digital cognitive assessments for a phase III autoimmune disease trial. Revenue from the contract is expected over the next three years. Read More
